Gastrointestinal Intervention 2018; 7(1): 1-1  https://doi.org/10.18528/gii18000
Greetings from the Guest Editor
Edward Wolfgang Lee
Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Published online: April 30, 2018.
© Society of Gastrointestinal Intervention. All rights reserved.

cc This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Body

Chronic liver diseases causing liver cancers and portal hypertension are endless and difficult clinical challenges for physicians including gastroenterologists, hepatologists, oncologists, surgeons, interventional and diagnostic radiologists and primary care physicians. Especially, the complexity and undetermined pathophysiology of portal hypertension add even more clinical enigma to our patient care.

Recent advancements in diagnostic imaging and minimally invasive interventional procedures have improved the way we treat our patients with chronic liver diseases. In this issue of Gastrointestinal Intervention focused on some of these advancements in interventional procedures, especially in transjugular intrahepatic portosystemic shunt (TIPS) for treatment of chronic liver diseases and severe portal hypertension. We present several comprehensive reviews including basic anatomy of portal hypertension and its natural portosystemic shunts, an updated review on portal vein embolization, new advancements in TIPS including a newly developed covered TIPS endoprosthesis and intravascular ultrasound-guided (IVUS) TIPS and finally, recent changes and trends of TIPS procedure in China. We hope this issue of Gastrointestinal Intervention can provide new information that can stimulate more research and collaborations to answer some of the unknown knowledge in treatment of chronic liver diseases and portal hypertension.



This Article


Cited By Articles
  • CrossRef (0)

Services
Social Network Service

e-submission

Archives